The findings open up potential to test for biomarkers and facilitate more focused management of patients with the condition.

The largest study to investigate the role of inflammatory biomarkers in hospitalized COVID-19 patients uncovers risk factors for worse health outcomes in those with diabetes.

For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.

A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.

Preliminary observations of COVID-19 patients with diabetes inspired an algorithm for glucose monitoring that’s suspected to help combat the virus’ serious complications.

A physician-scientist explains his latest research in the area.